CARM1 and neoplasm: Promising CARM1 inhibitors include EPZ022302/EZM2302 (a 6 nM CARM1 inhibitor with anti-tumour activity in vivo) [23] and TP-064 (IC50 < 10 nM against CARM1 and >100-fold selective over other methyltransferases) [32].